pubmed-article:6143539 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6143539 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
pubmed-article:6143539 | lifeskim:mentions | umls-concept:C0042523 | lld:lifeskim |
pubmed-article:6143539 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
pubmed-article:6143539 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:6143539 | lifeskim:mentions | umls-concept:C0079043 | lld:lifeskim |
pubmed-article:6143539 | lifeskim:mentions | umls-concept:C1512045 | lld:lifeskim |
pubmed-article:6143539 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:6143539 | pubmed:dateCreated | 1984-5-10 | lld:pubmed |
pubmed-article:6143539 | pubmed:abstractText | Different, dose-dependent effects of verapamil inhalation on histamine-induced bronchoconstriction in anaesthetized dogs are reported. Cumulative histamine dose-response curves were obtained on three groups each consisting of six dogs. These groups were: A - after atropine sulphate (1 mg/kg); B - after atropine sulphate and verapamil (approximately 0.5 mg/kg); C - after atropine sulphate and verapamil (approximately 5.0 mg/kg). Total lung resistance (R1) was measured as the indicator of bronchoconstriction. The mean maximal response of R1 in B was significant greater (p less than 0.01) than in A and C, while no significant difference was observed between A and C. A possible mechanism is postulated. | lld:pubmed |
pubmed-article:6143539 | pubmed:language | eng | lld:pubmed |
pubmed-article:6143539 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6143539 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6143539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6143539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6143539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6143539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6143539 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6143539 | pubmed:month | Feb | lld:pubmed |
pubmed-article:6143539 | pubmed:issn | 0301-4533 | lld:pubmed |
pubmed-article:6143539 | pubmed:author | pubmed-author:BunnA EAE | lld:pubmed |
pubmed-article:6143539 | pubmed:author | pubmed-author:KrivoyNN | lld:pubmed |
pubmed-article:6143539 | pubmed:author | pubmed-author:BrandtH DHD | lld:pubmed |
pubmed-article:6143539 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6143539 | pubmed:volume | 267 | lld:pubmed |
pubmed-article:6143539 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6143539 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6143539 | pubmed:pagination | 328-34 | lld:pubmed |
pubmed-article:6143539 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:meshHeading | pubmed-meshheading:6143539-... | lld:pubmed |
pubmed-article:6143539 | pubmed:year | 1984 | lld:pubmed |
pubmed-article:6143539 | pubmed:articleTitle | Different, dose-dependent effects of verapamil inhalation on histamine-induced bronchoconstriction in anaesthetized dogs. | lld:pubmed |
pubmed-article:6143539 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6143539 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |